CIK 0001367644 · Accelerated filer
Emergent BioSolutions Inc.
Sign in to watch- Ticker
- EBS
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 141902018
- Phone
- 240-631-3200
- Business address
- 300 PROFESSIONAL DR, GAITHERSBURG, MD, 20879
- 4 Returned to the company SVP, Bioservices returned 5,771 shares (to the company)
- 4 Returned to the company EVP, Chief Financial Officer returned 46,155 shares (to the company)
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 8-K Event Regulation FD disclosure
- 8-K Event Regulation FD disclosure
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Shares withheld for taxes SVP, R&D, CMO gave up 3,543 shares (to pay taxes)
- 8-K Event Regulation FD disclosure
- 4 Open-market sale Director sold 21,984 shares at an average $11.97 ($263,077)
- 144 Insider Sale of Securities
- 4 Shares withheld for taxes SVP, Bioservices gave up 610 shares (to pay taxes)
- 4 Open-market sale Director sold 17,801 shares at $10.54 ($187,623)
- 8-K Event Executive or director change · Regulation FD disclosure
- 4 Open-market sale Director sold 8,552 shares at $10.00 ($85,520)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Regulation FD disclosure
Page 5 of 87 · 1,733 filings